FY26 Novel approaches to support therapeutic development in ultra-rare cancers
Type: Forecast
Overview
Description
The Oncology Center of Excellence's (OCE's) Scientific Collaborative Program has led the way in supporting groundbreaking research efforts in oncology and drug development, contributing greatly to the FDA public health mission.
Est. Value
Min: $700,000
Max: $1,500,000
Max: $1,500,000
Est. Award Date
5/1/26
Source Est. Solicitation Date
3/1/26
Set Aside
Full and Open
Forecast Type
New
Forecast Source
Health and Human Services
Centers for Disease Control and Prevention is forecasted to issue a new procurement for FY26 Novel approaches to support therapeutic development in ultra-rare cancers around 5/1/26 worth up to $1,500,000.
Agency
Source Level 1 Agency
Health and Human Services
Source Level 2 Agency
Centers for Disease Control and Prevention
Contacts
Potential Bidders and Partners
Similar Active Opportunities
Additional Detail
Date Published
11/19/25